Literature DB >> 3885695

Magnetic resonance imaging of aneurysms of the abdominal aorta.

B Flak, D K Li, B Y Ho, W J Knickerbocker, S Fache, J Mayo, W Chung.   

Abstract

Experience with magnetic resonance imaging (MRI) of 10 normal control patients and 13 patients with known abdominal aortic aneurysms is presented. The aorta, renal artery origins, and iliac arteries were clearly identified in all control patients. Ten out of 13 aneurysms were optimally visualized. Three cases early in the experience were poorly seen and permitted less confident measurements. Renal artery origins were identified in 12 cases and judged to be uninvolved by the aneurysm in 11. Iliac arteries were identified in 11 cases and judged to be definitely aneurysmal in three. Sonography clearly depicted all 13 aneurysms. Correlation of the actual anteroposterior (AP) and transverse diameter aneurysm measurements with both techniques was excellent. Sonography failed to identify the renal artery origins in all cases, but could infer noninvolvement in two cases. Iliac arteries were seen in eight cases and judged definitely aneurysmal in three. According to these preliminary results, both MRI and sonography provide accurate AP and transverse outer wall measurements. MRI is superior in determining the presence of renal and/or iliac involvement. The authors recommend, however, that sonography continue to be the preliminary screening method.

Entities:  

Mesh:

Year:  1985        PMID: 3885695     DOI: 10.2214/ajr.144.5.991

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  2 in total

1.  Magnetic resonance angiography of the abdominal aorta.

Authors:  I P Arlart; L Guhl; R R Edelman
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Jan-Feb       Impact factor: 2.740

2.  Preoperative evaluation of abdominal aortic aneurysm by MR imaging with aortography correlation.

Authors:  D B Koslin; P J Kenney; F S Keller; R E Koehler; G M Gross
Journal:  Cardiovasc Intervent Radiol       Date:  1988-12       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.